Similar response? LOL
1 is 50%, the others didn't even say anything, but with lesion rate of ~40%, the last one is not in phase 1 yet.
We are in phase 1, a bit slower than the first company which is in phase 2. We have 95% (albeit small sampling size), they have 50%.
I don't know, looks pretty good to me. Similar? Not even close.
Ann: Admedus announces further data from HSV-2 Trial, page-82
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.50 |
Change
-0.400(3.10%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $12.71 | $12.71 | $12.30 | $131.3K | 10.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 85 | $11.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.50 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |